{
    "root": "98a69c58-33de-41e1-a26f-7a4152605f05",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Desonide",
    "value": "20250307",
    "ingredients": [
        {
            "name": "DESONIDE",
            "code": "J280872D1O",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_204734"
        },
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11058"
        }
    ],
    "indications": {
        "text": "desonide ointment , 0.05 % low potency corticosteroid indicated relief inflammatory pruritic manifestations corticosteroid responsive dermatoses . used longer two weeks unless directed physician .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "desonide ointment , 0.05 % applied affected area thin film two four times daily depending severity condition . corticosteroids , therapy discontinued control achieved . improvement seen within two weeks , reassessment diagnosis may necessary . desonide ointment , 0.05 % used occlusive dressings .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "desonide ointment , 0.05 % available follows : 15 g tube ( ndc 46708-485-15 ) 60 g tube ( ndc 46708-485-60 )",
    "adverseReactions": "desonide ointment , 0.05 % contraindicated patients history hypersensitivity components preparation .",
    "indications_original": "Desonide ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.\n                  It should not be used for longer than two weeks unless directed by a physician.",
    "contraindications_original": "Desonide ointment, 0.05% should be applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary.\n                  Desonide ointment, 0.05% should not be used with occlusive dressings.",
    "warningsAndPrecautions_original": "Desonide Ointment, 0.05% is available as follows:\n                  15 g tube (NDC 46708-485-15)\n                  60 g tube (NDC 46708-485-60)",
    "adverseReactions_original": "Desonide ointment, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.",
    "drug": [
        {
            "name": "Desonide",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_204734"
        }
    ]
}